Literature DB >> 15036232

Human CD4+CD25+ regulatory T cells.

Clare Baecher-Allan1, Vissia Viglietta, David A Hafler.   

Abstract

In this report, we review studies of human CD4+CD25+ regulatory T cells (T-reg). Although lagging a few years behind the discovery of these cells in the mouse, the equivalent population of CD4+CD25+ regulatory T cells has also been isolated from human peripheral blood, thymus, lymph nodes and cord blood. In general, the characteristics of this T cell subset are strikingly similar between mouse and man. In the recent explosion of research reports on human CD4+CD25+ cells, although the majority of the characteristics ascribed to these cells appear to be consistent, contrasting results have been found primarily in regards to potential involvement of TGFbeta and production of IL-10. One explanation for this variability may reside in the fact that markedly different techniques are used to isolate human CD4+CD25+ T-reg cells and thus may result in the comparison of T-reg populations that differ in cellular composition and/or activation state. Another potential explanation for differences in human T-reg function may rest on the extreme variability of the culture conditions and TCR stimuli that have been used to test the functional properties of these cells in vitro. The strength of the TCR signal provided to the culture greatly affects the functional outcome of the co-culture and can result in the difference between suppression and full activation. Surprisingly, it appears that stronger stimulation has a greater and more rapid effect on the T-resp cell than on the T-reg cell as it causes T-resp cells to quickly become resistant to suppression. Thus, the details of in vitro culture conditions may at least partially account for disparate findings in regard to the functional characterization of human CD4+CD25+ cells. Here we review the evidence regarding the identification of human CD4+CD25+ regulatory T cells and their possible mechanism(s) of function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036232     DOI: 10.1016/j.smim.2003.12.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  118 in total

1.  Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX).

Authors:  A C Bakke; M Z Purtzer; R S Wildin
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

2.  Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia.

Authors:  Giovanni Sais; Stephen Wyler; Tvrtko Hudolin; Irina Banzola; Chantal Mengus; Lukas Bubendorf; Peter J Wild; Hans H Hirsch; Tullio Sulser; Giulio C Spagnoli; Maurizio Provenzano
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

Review 3.  The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention.

Authors:  Joanna Domagala-Kulawik
Journal:  Transl Lung Cancer Res       Date:  2015-04

4.  Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses.

Authors:  Hyung W Lim; Peter Hillsamer; Chang H Kim
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 5.  CD4+ regulatory cells as a potential immunotherapy.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

6.  Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.

Authors:  Zhi-Zhang Yang; Anne J Novak; Mary J Stenson; Thomas E Witzig; Stephen M Ansell
Journal:  Blood       Date:  2006-01-10       Impact factor: 22.113

7.  Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood T cells in children born to mothers with type 1 diabetes.

Authors:  B C Holm; J Svensson; C Akesson; J Arvastsson; J Ljungberg; K Lynch; S-A Ivarsson; A Lernmark; C M Cilio
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

8.  In vitro Treg suppression assays.

Authors:  Lauren W Collison; Dario A A Vignali
Journal:  Methods Mol Biol       Date:  2011

9.  Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus.

Authors:  N I Rallón; M López; V Soriano; J García-Samaniego; M Romero; P Labarga; P García-Gasco; J González-Lahoz; J M Benito
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 10.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.